These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10820005)

  • 1. Identification of a binding site for quaternary amines in factor Xa.
    Monnaie D; Arosio D; Griffon N; Rose T; Rezaie AR; Di Cera E
    Biochemistry; 2000 May; 39(18):5349-54. PubMed ID: 10820005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of residue Y99 in tissue plasminogen activator.
    Vindigni A; Winfield M; Ayala YM; Di Cera E
    Protein Sci; 2000 Mar; 9(3):619-22. PubMed ID: 10752624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator.
    Katz BA; Mackman R; Luong C; Radika K; Martelli A; Sprengeler PA; Wang J; Chan H; Wong L
    Chem Biol; 2000 Apr; 7(4):299-312. PubMed ID: 10779411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of cation-pi interactions in protein-ligand complexes: crystal-structure analysis of Factor Xa bound to a quaternary ammonium ion ligand.
    Schärer K; Morgenthaler M; Paulini R; Obst-Sander U; Banner DW; Schlatter D; Benz J; Stihle M; Diederich F
    Angew Chem Int Ed Engl; 2005 Jul; 44(28):4400-4. PubMed ID: 15952226
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium binding site of factor Xa: role of sodium in the prothrombinase complex.
    Rezaie AR; He X
    Biochemistry; 2000 Feb; 39(7):1817-25. PubMed ID: 10677232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombinase assembly and S1 site occupation restore the catalytic activity of FXa impaired by mutation at the sodium-binding site.
    Camire RM
    J Biol Chem; 2002 Oct; 277(40):37863-70. PubMed ID: 12149252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of P225 and the C136-C201 disulfide bond in tissue plasminogen activator.
    Vindigni A; Di Cera E
    Protein Sci; 1998 Aug; 7(8):1728-37. PubMed ID: 10082369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of residue 99 at the S2 subsite of factor Xa and activated protein C in enzyme specificity.
    Rezaie AR
    J Biol Chem; 1996 Sep; 271(39):23807-14. PubMed ID: 8798609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human coagulation factor xa. Studies on catalytic efficiency and inhibitor binding.
    Underwood MC; Zhong D; Mathur A; Heyduk T; Bajaj SP
    J Biol Chem; 2000 Nov; 275(47):36876-84. PubMed ID: 10973949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for inhibition promiscuity of dual specific thrombin and factor Xa blood coagulation inhibitors.
    Nar H; Bauer M; Schmid A; Stassen JM; Wienen W; Priepke HW; Kauffmann IK; Ries UJ; Hauel NH
    Structure; 2001 Jan; 9(1):29-37. PubMed ID: 11342132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
    Rezaie AR
    Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetics of thrombin-thrombomodulin interaction.
    Vindigni A; White CE; Komives EA; Di Cera E
    Biochemistry; 1997 Jun; 36(22):6674-81. PubMed ID: 9184147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism.
    Rezaie AR
    Biochemistry; 2004 Mar; 43(12):3368-75. PubMed ID: 15035608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding protein-ligand interactions: the price of protein flexibility.
    Rauh D; Klebe G; Stubbs MT
    J Mol Biol; 2004 Jan; 335(5):1325-41. PubMed ID: 14729347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
    Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
    J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New chromogenic substrates for thrombin with increased specificity.
    Kolde HJ; Eberle R; Heber H; Heimburger N
    Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.
    Sperl S; Bergner A; Stürzebecher J; Magdolen V; Bode W; Moroder L
    Biol Chem; 2000 Apr; 381(4):321-9. PubMed ID: 10839461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.